Ranzun Zhao
Overview
Explore the profile of Ranzun Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng C, Liu Z, Zhao R, Shi B
Int J Cardiol
. 2024 Dec;
421():132918.
PMID: 39689818
Despite significant advancements in drug-eluting stent technology, in-stent restenosis (ISR) still occurs in approximately 10 % of patients undergoing percutaneous coronary intervention, remaining a significant global health concern. The mechanisms...
2.
Gu N, Chen P, Wang X, Shen C, Deng Y, Chen J, et al.
J Cardiovasc Pharmacol
. 2024 Nov;
84(5):506-514.
PMID: 39509350
The aim of this study was to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation....
3.
Han W, Xiong W, Sun W, Liu W, Zhang Y, Li C, et al.
Cell Transplant
. 2024 Oct;
33:9636897241290910.
PMID: 39466658
The therapeutic efficacy of bone marrow mesenchymal stem cells (BMSCs) in myocardial infarction (MI) is hindered by poor cell survival. This study explored the role of N6-methyladenosine (m6A) regulation, specifically...
4.
Deng C, Liu Z, Li C, Xu G, Zhang R, Bai Z, et al.
Int J Cardiol
. 2024 Oct;
418:132610.
PMID: 39366560
Background: Cholesterol crystals (CCs) are recognized as a risk factor for vulnerable atherosclerotic plaque rupture (PR) and major adverse cardiovascular events. However, their predictive factors and association with plaque vulnerability...
5.
Hu X, He X, Zhang W, Jin C, Deng C, Ma Y, et al.
Int Immunopharmacol
. 2024 Sep;
142(Pt B):113203.
PMID: 39312859
Objective: Patients with infectious intracranial aneurysms (IIAs) have high mortality rates. Sepsis is an important condition that induces IIA. Smooth muscle cell (SMC) phenotypic switching may have a critical effect...
6.
Sheng J, Yang S, Gu N, Deng C, Shen Y, Xia Q, et al.
Heliyon
. 2024 Sep;
10(16):e36486.
PMID: 39253253
Background: In-stent neoatherosclerosis (ISNA) is identified as the primary cause of in-stent restenosis (ISR). The systemic immune inflammation index (SII), shows promise for predicting post-percutaneous coronary intervention (PCI) adverse cardiovascular...
7.
Gao Y, Wang Y, Zhao R, Yang D, Chen L, Shi B
Medicine (Baltimore)
. 2024 Sep;
103(36):e36401.
PMID: 39252280
Rationale: Tachycardia is a common arrhythmia in clinical practice, and its pathogenesis is mostly related to reentry. However, there are also a few tachycardia that are not related to reentry....
8.
Xia Q, Deng C, Yang S, Gu N, Shen Y, Shi B, et al.
Clin Cardiol
. 2024 Aug;
47(8):e24332.
PMID: 39119892
Background: Stent malapposition (SM) following percutaneous coronary intervention (PCI) for myocardial infarction continues to present significant clinical challenges. In recent years, machine learning (ML) models have demonstrated potential in disease...
9.
Deng C, Liu Z, Zhang W, Deng Y, Liu H, Bai Z, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(12):341.
PMID: 39077084
Background: Neoatherosclerosis (NA) is associated with stent failure. However, systematic studies on the manifestations of NA and neovascularization (NV) at different stages after drug-eluting stent (DES) implantation are lacking. Moreover,...
10.
Gu N, Shen Y, He Y, Li C, Xiong W, Hu Y, et al.
J Mol Cell Cardiol
. 2024 May;
194:16-31.
PMID: 38821243
Background: Hypoxia-induced pulmonary artery hypertension (HPH) is a complication of chronic hypoxic lung disease and the third most common type of pulmonary artery hypertension (PAH). Epigenetic mechanisms play essential roles...